{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:55:31Z","timestamp":1778000131018,"version":"3.51.4"},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,10,31]],"date-time":"2003-10-31T00:00:00Z","timestamp":1067558400000},"content-version":"vor","delay-in-days":2282,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:p>The effect of medetomidine, a potent and highly selective \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptor agonist, on the motility of the gastric antrum, duodenum, mid\u2010jejunum and ileum was investigated in ten dogs. Its effect on the release of gastrin was also determined. Administration of medetomidine intramuscularly (i.m.) at a dose of 40 \u03bcg\/kg inhibited the motility of the gastric antrum, duodenum, mid\u2010jejunum and ileum significantly, in comparison to administration of xylazine intramuscularly at a dose of 2.0 mg\/kg. The release of gastrin was also significantly decreased in dogs receiving medetomidine. It was found to inhibit the motility in the gastric antrum and duodenum longer than in the mid\u2010jejunum and ileum, presumably by acting specifically on \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptors, likely at the peripheral level. Medetomidine also inhibited the gastric contraction associated with gastrin secretion.<\/jats:p>","DOI":"10.1046\/j.1365-2885.1997.00068.x","type":"journal-article","created":{"date-parts":[[2003,11,2]],"date-time":"2003-11-02T17:11:36Z","timestamp":1067793096000},"page":"290-295","source":"Crossref","is-referenced-by-count":17,"title":["The effects of medetomidine and xylazine on gastrointestinal motility and gastrin release in the dog"],"prefix":"10.1111","volume":"20","author":[{"given":"K.","family":"NAKAMURA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"HARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"TOMIZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,31]]},"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2885.1997.00068.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2885.1997.00068.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2885.1997.00068.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:59:28Z","timestamp":1694419168000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2885.1997.00068.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1046\/j.1365-2885.1997.00068.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2885.1997.00068.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}